Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

Wijesinghe, H., Galappatthy, P., de Silva, R., Seneviratne, S.L., Saravanamuttu, U., Udagama, P., Hart, M., Kelleher, P., Senarath, U., Fernandopulle, R. and Weerasekera, L.P.,
BMC Musculoskeletal Disorders, 18(1), p.310.
Publication year: 2017

Leave a Reply

Your email address will not be published. Required fields are marked *